US Equity
BIIB
— BIOGEN INC.Biogen is a biotechnology company that develops therapies for neurological and neurodegenerative diseases, including multiple sclerosis and Alzheimer's disease.
💰 Market cap: $29.55B📍 225 Binney Street, CAMBRIDGE, MA, 02142 US🏷️ Pharmaceuticals💵 Previous close: $202.19🔢 9,878 credits left
Add Column
All
Trend
| Date ▾ | Close ▾ |
|---|---|
| 2026-07-24 | $202.19 |
| 2026-07-23 | $200.62 |
| 2026-07-22 | $197.74 |
| 2026-07-21 | $203.16 |
| 2026-07-20 | $199.95 |
| 2026-07-17 | $205.99 |
| 2026-07-16 | $208.92 |
| 2026-07-15 | $197.24 |
| 2026-07-14 | $191.95 |
| 2026-07-13 | $209.03 |
| 2026-07-10 | $199.15 |
| 2026-07-09 | $198.91 |
| 2026-07-08 | $200.36 |
| 2026-07-07 | $205.70 |
| 2026-07-06 | $208.46 |
| 2026-07-02 | $216.12 |
| 2026-07-01 | $209.74 |
| 2026-06-30 | $216.06 |
| 2026-06-29 | $216.63 |
| 2026-06-26 | $216.03 |
| 2026-06-25 | $201.96 |
| 2026-06-24 | $199.59 |
| 2026-06-23 | $197.19 |
| 2026-06-22 | $199.71 |
| 2026-06-18 | $196.58 |
| 2026-06-17 | $198.67 |
| 2026-06-16 | $195.61 |
| 2026-06-15 | $198.64 |
| 2026-06-12 | $200.05 |
| 2026-06-11 | $199.96 |
| 2026-06-10 | $194.24 |
| 2026-06-09 | $199.10 |
| 2026-06-08 | $192.62 |
| 2026-06-05 | $195.34 |
| 2026-06-04 | $196.45 |
| 2026-06-03 | $195.96 |
| 2026-06-02 | $188.83 |
| 2026-06-01 | $192.23 |
| 2026-05-29 | $196.00 |
| 2026-05-28 | $196.39 |
| 2026-05-27 | $196.97 |
| 2026-05-26 | $193.08 |
| 2026-05-22 | $193.76 |
| 2026-05-21 | $189.47 |
| 2026-05-20 | $187.80 |
| 2026-05-19 | $190.56 |
| 2026-05-18 | $191.91 |
| 2026-05-15 | $192.95 |
| 2026-05-14 | $191.37 |
| 2026-05-13 | $204.53 |
| 2026-05-12 | $199.36 |
| 2026-05-11 | $197.95 |
| 2026-05-08 | $193.45 |
| 2026-05-07 | $191.38 |
| 2026-05-06 | $190.68 |
| 2026-05-05 | $189.13 |
| 2026-05-04 | $187.21 |
| 2026-05-01 | $187.06 |
| 2026-04-30 | $189.28 |
| 2026-04-29 | $194.38 |
| 2026-04-28 | $183.38 |